Cargando…

Identification of Highly Sensitive Pleural Effusion Protein Biomarkers for Malignant Pleural Mesothelioma by Affinity-Based Quantitative Proteomics

SIMPLE SUMMARY: The development of malignant pleural mesothelioma, a rare and often aggressive cancer associated with asbestos exposure, can take decades to develop. The existing methods for diagnosis are insufficient, hence, better detection methods are required. Given that pleural effusions are cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palstrøm, Nicolai B., Overgaard, Martin, Licht, Peter, Beck, Hans C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913626/ https://www.ncbi.nlm.nih.gov/pubmed/36765599 http://dx.doi.org/10.3390/cancers15030641

Ejemplares similares

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion
por: Tsuji, S, et al.
Publicado: (2010)

Interleukin‐5‐producing malignant pleural mesothelioma with eosinophilic pleural effusion
por: Takeuchi, Eiji, et al.
Publicado: (2020)

Management of Pleural Effusion Secondary to Malignant Mesothelioma
por: Musso, Valeria, et al.
Publicado: (2021)

MicroRNA Signatures in Malignant Pleural Mesothelioma Effusions
por: Birnie, Kimberly A., et al.
Publicado: (2019)

Hyaluronic acid in viscous malignant mesothelioma pleural effusion
por: Cheah, Hui Min, et al.
Publicado: (2020)

Malignant pleural mesothelioma presenting with remitting–relapsing pleural effusions: report of two cases
por: Muruganandan, Sanjeevan, et al.
Publicado: (2018)

Circulating biomarkers in malignant pleural mesothelioma
por: Viscardi, Giuseppe, et al.
Publicado: (2020)

A Case of Pulmonary Embolism with Sarcomatoid Malignant Pleural Mesothelioma with Long-Term Pleural Effusion
por: Gu, Rumeng, et al.
Publicado: (2021)

Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions
por: Szulkin, Adam, et al.
Publicado: (2014)

Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)

MicroRNA and mRNA Features of Malignant Pleural Mesothelioma and Benign Asbestos-Related Pleural Effusion
por: Ak, Guntulu, et al.
Publicado: (2015)

Pleural effusion biomarkers and computed tomography findings in diagnosing malignant pleural mesothelioma: A retrospective study in a single center
por: Otoshi, Takehiro, et al.
Publicado: (2017)

Pleural biomarkers in diagnostics of malignant pleural effusion: a narrative review
por: Zhang, Man, et al.
Publicado: (2021)

Proteome Screening of Pleural Effusions Identifies Galectin 1 as a Diagnostic Biomarker and Highlights Several Prognostic Biomarkers for Malignant Mesothelioma
por: Mundt, Filip, et al.
Publicado: (2014)

Pleural Mesothelioma: Advances in Blood and Pleural Biomarkers
por: Sorino, Claudio, et al.
Publicado: (2023)

Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion
por: Chen, Kuan-Yuan, et al.
Publicado: (2016)

Improved diagnosis and prognostication of patients with pleural malignant mesothelioma using biomarkers in pleural effusions and peripheral blood samples – a short report
por: Beije, Nick, et al.
Publicado: (2017)

Diagnostic value of soluble mesothelin-related peptides in pleural effusion for malignant pleural mesothelioma: An updated meta-analysis
por: Gao, Ruiyue, et al.
Publicado: (2019)

Liquid Biopsies from Pleural Effusions and Plasma from Patients with Malignant Pleural Mesothelioma: A Feasibility Study
por: Moretti, Gabriele, et al.
Publicado: (2021)

Quantitative Clinical Staging for Patients With Malignant Pleural Mesothelioma
por: Gill, Ritu R, et al.
Publicado: (2017)

Discriminating Tuberculous Pleural Effusion from Malignant Pleural Effusion Based on Routine Pleural Fluid Biomarkers, Using Mathematical Methods
por: Darooei, Reza, et al.
Publicado: (2017)

Malignant pleural mesothelioma in Italy
por: Bianchi, Claudio, et al.
Publicado: (2009)

Heterogeneity in Malignant Pleural Mesothelioma
por: Oehl, Kathrin, et al.
Publicado: (2018)

Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020)

Malignant pleural mesothelioma: an update
por: Hajj, Glaucia N. M., et al.
Publicado: (2021)

Malignant pleural mesothelioma in situ
por: Ando, Kohei, et al.
Publicado: (2022)

Prediction modeling using routine clinical parameters to stratify survival in malignant pleural mesothelioma patients complicated with malignant pleural effusion
por: Zhang, Shu, et al.
Publicado: (2021)

Clinical identification of malignant pleural effusions
por: Jia, Jianlong, et al.
Publicado: (2023)

Management of malignant pleural effusion with different pleural catheters
por: Karapolat, Sami, et al.
Publicado: (2018)

Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma
por: Yang, Haitang, et al.
Publicado: (2020)

A case of pleural mesothelioma with effusive-constrictive pericarditis.
por: Weir, N. A., et al.
Publicado: (2001)

Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas
por: Sriram, Krishna B, et al.
Publicado: (2012)

Mediastinal undifferentiated pleomorphic sarcoma with pleural effusion cytopathologically misdiagnosed as epithelial malignant pleural mesothelioma: An autopsy case report
por: Matsumoto, Kinnosuke, et al.
Publicado: (2021)

High-throughput autoantibody analysis in malignant pleural effusion and tuberculosis pleural effusion
por: Yi, Fengshuang, et al.
Publicado: (2019)

Role of Prosaposin and Extracellular Sulfatase Sulf-1 Detection in Pleural Effusions as Diagnostic Biomarkers of Malignant Mesothelioma
por: Zallocco, Lorenzo, et al.
Publicado: (2022)

Management of Malignant Pleural Effusions
por: Villanueva, Andrew G.
Publicado: (2012)

Management of Malignant Pleural Effusions
por: Charpidou, Adrianni, et al.
Publicado: (2006)

Pleural Fluid Mesothelin as an Adjunct to the Diagnosis of Pleural Malignant Mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2014)

GC‐MS metabolomics identifies novel biomarkers to distinguish tuberculosis pleural effusion from malignant pleural effusion
por: Liu, Yongxia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ggjlflmpj66pbsl0gdovu4t8rb